UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Discipline keeps budgets on track amid temptations to overspend. Learn why steady habits matter and how to cultivate them for lasting budgeting success.
23,814 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Could buying Joby Aviation stock set you up for life? This guide breaks down the opportunity, risks, and a practical ...
Two ad-tech leaders with different business models, The Trade Desk and AppLovin, reveal distinct quarterly revenue pa...
Investors are keeping a close eye on Co-Diagnostics as 2025 earnings unfold. This guide breaks down what to look for ...
Small business owners may tap the augusta rule: small business to host company events at home for up to 14 days, crea...
HUD launches two tech-enabled pilots designed to increase housing supply and cut costs. The programs target robotics ...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...
A seasoned market watcher outlines a bold bull case for Bitcoin and Ethereum, suggesting cryptocurrencies poised soar...
When a mid-size firm makes a bold move into quantum tech, the market watches closely. This piece breaks down what Try...
BlackRock’s DYNF uses active factor rotation to chase leadership across value, quality, momentum, and more. As market...
Real estate lenders and agents are adopting an education-first approach that centers on trust and client empowerment....
This article breaks down riskified (rskd) 2026 earnings, explaining what the latest results mean for growth, profitab...